Carla Spina

Carla Spina, PhD. CEO & Co-Founder. Carla over 20 years of experience in life science. She led the development of novel topical antimicrobials, from discovery through to Phase Ib/IIa clinical study, and the development and commercialization of 6six Class II/III drug-device products, resulting in global license through 3M. She leverages a foundational knowledge in chemistry from her Ph.D. at McGill University with Dr. D.S. Bohle, Canadian Chair in Bioinorganic chemistry.